UGenome
  • Home
    • 1-minute UGenome overview
  • About
    • UGenome in the News
    • About
    • Contact
    • Team
    • Advisors
    • Partners & Collaborators
    • UGenome’s Mission, Vision, Values
    • UGenome Policies October 2025
    • Investors
  • Genomic Software
  • Bioinformatics
    • Bioinformatics Services
    • Bioinformatics Case Studies
  • Medication Response Solutions
    • UGenome’s PGx Case Studies
    • Emerging Trends
    • Rare Disease & Women’s Health Resources
    • Dictionary
Select Page

Pharmacogenomics, Nutrigenomics, and Longevity

by Brooks | Sep 20, 2025 | Emerging Trends, Nutrigenomics, Pharmacogenomics, Precision Health Personalized Medicine

Husna Rahim, PharmD, RPh & Zachary S. Brooks, PhD Integration of pharmacogenomic (PGx) data with nutritional genomics offers promising pathways for extending healthspan and promoting longevity ︎ Clinical implementation guidelines from CPIC and DPWG provide...

Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics

by Brooks | Jul 6, 2025 | Clinical outcomes, Emerging Trends, Next generation sequencing, Pharmacogenomics, Reduce Adverse Drug Reactions

Jennifer Tovar, PharmD & Husna Rahim, PharmD Improving Clinical Outcomes: Next Generation Sequencing and Pharmacogenomics. How has Next Generation Sequencing (NGS) transformed the field of pharmacogenomics (PGx)? NGS, also known as massive parallel sequencing, is...

Pharmacogenomics: Rethinking Mental Health

by Brooks | Jul 6, 2025 | Emerging Trends, Mental Health and Psychiatry, Pharmacogenomics

Jennifer Tovar, PharmD & Hanna M. Schultze, MD, DE, EMBA Pharmacogenomics: Rethinking Mental Health. How might pharmacogenomics (PGx) reshape the treatment paradigm for mental health disorders? Mental health PGx is a rapidly evolving field at the intersection of...

Pharmacogenomics: Ensuring Equitable Benefits for Underserved Patient Populations

by Brooks | Jul 6, 2025 | Emerging Trends, Inequities - Underrepresented, Pharmacogenomics

Zachary Brooks, PhD & Archana Gurudu Pharmacogenomics: Ensuring Equitable Benefits for Underserved Patient Populations. How can pharmacogenomic (PGx) research and testing promote health equity in patients of underserved backgrounds? PGx remains a foundational...

UGenome AI and Kaüna partner to Advance Pharmacogenetics in Kidney Care

by Brooks | Jun 5, 2025 | Kidney-Renal, News, Pharmacogenomics, Transplant

for immediate release June 5, 2025 05:00 a.m. Pacific Standard Time & 8:00 a.m. Eastern Standard Time TUCSON, A.Z. – UGenome AI, a pioneer in genomic platforms to fuel personalized medicine, today announced a strategic partnership with Kaüna to deliver medication...

Have YOU EVER WONDERED …why NSAID use in women calls for extra care?

by Brooks | Jun 4, 2025 | Pharmacogenomics, Precision Health Personalized Medicine, Reduce Adverse Drug Reactions, Women's Health, Wondered?

Navya Brinda & Zoe Huestis Have YOU EVER WONDERED …why NSAID use in women calls for extra care? NSAIDs are the most widely used pain and anti-inflammatory medications, with higher usage reported in women than men (Farkouh et al., 2021) Women are twice as...
« Older Entries

Recent Posts

  • Could Genetic Biomarkers Transform Kidney Disease Treatment?  
  • How Do National Genome Projects Advance the Power of Pharmacogenomics? 
  • How can Pharmacogenomics Protect Older Adults from the Risks of Polypharmacy?
  • Can Genetic Insights Refine Arrhythmia Treatment?
  • Pharmacogenomics, Nutrigenomics, and Longevity

Recent Comments

No comments to show.

UGenome Social Media

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

Sign up for UGenome's Newsletter on LinkedIn!

 

Click Here
Website built by The Free Website Guys 🚀
  • Follow
  • Follow